| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.41B | +7.4% | +41.0% |
| Gross Profit | $1.22B | +5.7% | +46.3% |
| R&D Expense | $523.7M | -0.2% | +5.5% |
| SG&A Expense | $529.0M | -1.7% | +16.2% |
| Operating Income | $163.1M | +85.6% | +235.6% |
| Interest Expense | $12.7M | +5.0% | -11.6% |
| Pre-tax Income | $147.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.04B | +46.5% | +49.4% |
| Accounts Receivable | $863.3M | +12.0% | +51.7% |
| Inventory | $531.7M | +5.7% | +23.2% |
| Current Assets | $5.66B | +31.4% | +44.8% |
| Total Assets | $7.63B | +21.2% | +30.9% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $710.2M | — | — |
| Capital Expenditures | $148.3M | — | — |
| Investing Cash Flow | -$237.8M | — | — |
| Financing Cash Flow | $962.5M | — | — |
| Free Cash Flow | $561.9M | — | — |
| +47.8% |
| +249.7% |
| Income Tax | $22.3M | +326.9% | -3.1% |
| Net Income | $124.8M | +32.4% | +202.9% |
| EPS (Basic) | $0.09 | +28.6% | +200.0% |
| EPS (Diluted) | $0.08 | +33.3% | +188.9% |
| $2.37B |
| +7.2% |
| +16.9% |
| Total Liabilities | $3.50B | +38.6% | +46.3% |
| Stockholders' Equity | $4.13B | +9.5% | +20.2% |